LimFlow Inc is a Santa Clara-based company specializing in the development and distribution of the LimFlow System, an innovative medical device approved for sale in CE Mark regulated markets. With a focus on Chronic Limb-Threatening Ischemia (CLTI), the company aims to provide effective solutions for patients suffering from this condition.
Through their dedication to clinical evidence and international trials, LimFlow Inc has established itself as a leading player in the field, offering cutting-edge technology to address the needs of CLTI patients worldwide. With a commitment to improving patient outcomes, the company continues to make strides in the medical community.
Generated from the website